Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Thyroid. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Quantification of Symptom Relief Following Percutaneous Ablation of the Thyroid
Overview
The purpose of this study is to measure the impact of thyroid radiofrequency ablation procedure on patients with thyroid-related symptoms using a modified pre-existing scoring system.
Primary outcome measures
- Change in symptoms before and after ablation [Time frame: Baseline and 1-, 3-, 6-, 12-, 18-, and 24-months following treatment]
Eligibility criteria
Inclusion criteria
\- Undergoing Radiofrequency Ablation (RFA) for symptomatic thyroid nodule(s).
Exclusion criteria
\- Decline to participate in research.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Mayo Clinic Rochester — Rochester
Identifiers
NCT: NCT05501041 · 22-007581